How Much Did Etiometry Raise?
Funding & Key Investors

Etiometry, a prominent player in the clinical decision-support software sector, has successfully secured a major strategic investment, bringing its total capital accumulation to $9.4M. This latest infusion of $9M underscores the company's pivotal role in transforming intensive care unit workflows through advanced data analytics. By leveraging this recent financing, the Massachusetts-based firm is well-positioned to accelerate its enterprise-level expansion and solidify its market presence in the high-acuity healthcare technology landscape.

What is Etiometry?

Etiometry
SoftwareHealthcare Software

Founded in 2010, Etiometry specializes in sophisticated software solutions engineered to assist clinicians in the intensive care setting. The company's platform integrates complex physiological data to facilitate evidence-based decision-making, ultimately improving patient outcomes and operational efficiency. As a leader in the health-tech space, Etiometry addresses the critical need for real-time, actionable insights in high-stakes medical environments. Its market position is defined by a commitment to clinical rigor and technological innovation, serving as a vital bridge between raw patient data and life-saving medical interventions.

How much funding has Etiometry raised?

Etiometry has raised a total of $9.3M across 2 funding rounds:

2020

Debt

$350K

2021

Series A

$9M

Debt (2020): $350K with participation from PPP

Series A (2021): $9M led by SKK 9i Ventures and Shamrock Holdings

Key Investors in Etiometry

Shamrock Holdings

Shamrock Holdings is an investment firm founded by Roy E. Disney that emphasizes integrity and transparency while managing diverse portfolios including real estate and strategic enterprise ventures.

SKK 9i Ventures

A venture capital entity focused on identifying and supporting high-growth potential companies within the technology and healthcare sectors.

PPP

Public-Private Partnership

What's next for Etiometry?

With the successful closure of this major strategic investment, Etiometry is poised to enter a new phase of growth focused on scaling its enterprise-level infrastructure. The company is expected to prioritize the enhancement of its clinical decision-support algorithms and the expansion of its footprint within major hospital networks. By utilizing this capital to refine its product suite and broaden its reach, Etiometry aims to set new standards for data-driven care in intensive care units globally. The strategic trajectory suggests a focus on long-term sustainability and the continued integration of its software into the standard of care for critical patient management.

See full Etiometry company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Content & Collaboration SoftwareSoftwareCustomer Engagement Platforms
Content & Collaboration SoftwareSoftware
Engineering SoftwareSoftware
Customer Engagement PlatformsSoftwareMobile App Development

Frequently Asked Questions Regarding Etiometry Financial Insights

What are the most recent funding rounds that Etiometry has completed, and what were the funding rounds?
Etiometry has recently completed 2 funding rounds: Series A on Jun 3, 2021, Debt on Apr 10, 2020.
What is the total amount of funding Etiometry has raised to date?
Etiometry has raised a total of $9.3M in funding to date.
How many funding rounds has Etiometry completed?
Etiometry has completed 2 funding rounds.
How much funding did Etiometry raise in its most recent funding round?
Etiometry raised $9M in its most recent funding round.
Who are the lead investors in Etiometry's latest funding round?
The lead investor in Etiometry's latest funding round was SKK 9i Ventures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Etiometry's history?
The largest funding round in Etiometry's history was $9M.
See more information about Etiometry